Cerebrovascular, Cognitive and Cardiac Benefits of SGLT2 Inhibitors Therapy in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus: Results from a Global Federated Health Network Analysis.

Riccardo Proietti,José Miguel Rivera-Caravaca,Raquel López-Gálvez,Stephanie L Harrison,Francisco Marín,Paula Underhill,Eduard Shantsila,Garry McDowell,Manlio Vinciguerra,Rhys Davies,Clarissa Giebel,Deirdre A Lane,Gregory Y H Lip

Journal of clinical medicine（2023）

引用 4|浏览40

暂无评分

摘要

In our large 'real world' analysis of patients with concomitant AF and T2DM, SGLT2i reduced the risk of cerebrovascular events, incident dementia, heart failure and death.

查看译文

关键词

SGLT2,atrial fibrillation,dementia,stroke

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要